Precision Optics Enters into Production and Technology Licensing Agreement for Single-Use Cystoscopy Robotic Surgery Program
GARDNER, Mass., Dec. 4, 2023 /PRNewswire/ — Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense / aerospace industries, today announced it has signed a production and technology license agreement with a leading surgical robotics company to supply a single-use endoscope assembly used in their cystoscopy robotic surgery system.
Related news for (POCI)
- Precision Optics Expands Facilities to Meet Growing Backlog
- Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
- Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
- Precision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025
- Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025